News

Filter

1 to 9 of 23 results

Merck KGaA US units agree $44.3 million settlement with DoJ; Ranbaxy faces up to $1 billion fine?

05-05-2011

Four US subsidiaries of German drug major Merck KGaA (MRK: DE) - Serono Laboratories, EMD Serono, Merck…

LegalMerck KGaAMerck SeronoNorth AmericaPharmaceuticalRanbaxy LaboratoriesRebif

AstraZeneca settles with Teva over generic Nexium, so avoiding a court battle

08-01-2010

Anglo-Swedish drug major AstraZeneca has entered into an agreement with Israel-based generics giant Teva…

AstraZenecaEsomeprazole MagnesiumGastro-intestinalsGenericsLicensingMerck KGaANexiumOmeprazolePatentsPharmaceuticalPrilosecRanbaxy LaboratoriesTeva Pharmaceutical Industries

Access to Medicines: index praises GSK, as Sanofi-Aventis argues commercial case

21-07-2008

The issue of drug access in the less-developed parts of the world has provoked some discussion, especially…

Aventis PharmaGlaxoSmithKlineGSKIvermectinMerck KGaANovartisNovo NordiskRanbaxy LaboratoriesSanofi-AventisStromectol

Merck & Co and Ranbaxy in drug discovery/development accord

19-05-2008

US drug major Merck & Co has signed a strategic product development agreement with leading Indian firm…

Drug DiscoveryMerck KGaARanbaxy Laboratories

Ranbaxy withdraws bid for Merck KGaA's generics arm

26-03-2007

Indian drugmaker Ranbaxy Laboratories has withdrawn its bid for the generic drugs arm of Germany's Merck…

Merck KGaARanbaxy Laboratories

Ranbaxy bids for Merck KGaA's generics arm

19-03-2007

Indian drugmaker Ranbaxy Laboratories says that it has tabled a bid for the generics unit of Germany's…

Merck KGaARanbaxy Laboratories

1 to 9 of 23 results

COMPANY SPOTLIGHT

Menarini

Back to top